Plaintiffs UCB Pharma actions relates to Zydus has infringed one or more claims of the Reissued Patent No. RE 38,551 (“the ‘551 patent”) by filing the ANDA No. 204947 seeking approval for the commercial manufacture, use, offer for sale, sale and/or import of Zydus USA’s ANDA Products before the expiration of the ’551 patent
Complaint for Patent Infringement
Civil Action No. 3:13-cv-04021-MAS-TJB, the Hon. Michael A. Shipp presiding.
Filed on June 28, 2013 in the U.S. District Court for the District of New Jersey;
Patents in suit:
.
Complaint for Patent Infringement
Civil Action No. 3:13-cv-04021-MAS-TJB, the Hon. Michael A. Shipp presiding.
Filed on June 28, 2013 in the U.S. District Court for the District of New Jersey;
Patents in suit:
- RE 38,551: “Anticonvulsant enantiomeric amino acid derivatives” by Kohn. Prosecuted by Scully, Scott, Murphy & Presser. Includes 13 claims (1 indep.). Was application 08/818,688. Granted 6/30/1998.
.